Targeting CLDN18.2 by CD3 Bispecific and ADC Modalities for the Treatments of Gastric and Pancreatic Cancer
Published Online: 2019-06-10
Journal: Scientific Reports•Publisher: Springer Science and Business Media LLC
Authors: Adela Hasa-Moreno•Amy H. Yang•Charles Holz•Chenyu Lee•Davide Foletti•Eugenia Kraynov•Guoyun Zhu•Javier Chaparro-Riggers•Jody Melton Witt•Kevin C. Lindquist•Laura Aschenbrenner•Leslie Obert•Mathias Rickert•Pavel Strop•Sheng Ding•Shu-Hui Liu•Tao Sai•Thomas Van Blarcom•Tina Mistry•Winston Evering•Xiaohui Liu
